CD44 and urinary bladder cancer: Moreover, a recent research has found a self‐crosslinkable chitosan–HA dialdehyde nanoparticles could target the delivery of siRNA to T24 bladder cancer cells, which could affect bladder cancer through the interaction of CD44 and HA.289